TY - JOUR
T1 - The ERA Registry Annual Report 2022
T2 - Epidemiology of Kidney Replacement Therapy in Europe, with a focus on sex comparisions
AU - Boenink, Rianne
AU - Bonthuis, Marjolein
AU - Boerstra, Brittany A.
AU - Astley, Megan E.
AU - De Sousa, Iris R Montez
AU - Helve, Jakko
AU - Komissarov, Kirill
AU - Farnés, Jordi Comas
AU - Radunovic, Danilo
AU - Buchwinkler, Lukas
AU - Hommel, Kristine
AU - Gjorgjievski, Nikola
AU - Galvao, Ana A
AU - Mktsides, Nicos
AU - Vidas, Maria Marques
AU - Debska-Slizien, Alicja
AU - Ambrus, Csaba
AU - Slon Roblero, María F
AU - Ten Dam, Marc A G J
AU - Lassalle, Mathilde
AU - Guidotti, Rebecca
AU - Sanchez, Inmaculada Marin
AU - Kuzema, Viktorija
AU - Trujillo-Alemán, Sara
AU - Ziginskiene, Edita
AU - Santhakumaran, Shalini
AU - Valentin, Maria O
AU - Aunon, Antonio Sarrion
AU - Indridason, Ólafur S.
AU - Seyahi, Nurhan
AU - Larranaga, Marta Artamendi
AU - Kravljaca, Milica
AU - Okša, Adrián
AU - Lopez, Hector Garsia
AU - Asberg, Anders
AU - Rychlik, Ivan
AU - Ots-Rosenberg, Mai
AU - Beckerman, Pazit
AU - Kelmendi, Vjollca Godanci
AU - Stendahl, Maria
AU - Lakey, Joe
AU - Jager, Kitty J
AU - Ortiz, Alberto
AU - Kramer, Anneke
A2 - Stel, Vianda S
PY - 2024/12
Y1 - 2024/12
N2 - BackgroundThe European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with end-stage kidney disease (ESKD). This paper summarizes the ERA Registry Annual Report 2022, with a special focus on comparisons by sex. The supplement of this paper contains the complete ERA Registry Annual Report 2022.MethodsData was collected from 53 national and regional KRT registries from 35 countries. Using this data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities and expected remaining lifetimes were calculated.ResultsIn 2022, 530 million people of the European general population were covered by the ERA Registry. The incidence of KRT was 152 per million population (pmp). In incident patients, 54% were 65 years or older, 64% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22%). At KRT initiation, 83% of patients received haemodialysis, 12% received peritoneal dialysis, and 5% underwent preemptive kidney transplantation. On 31 December 2022, the prevalence of KRT was 1 074 pmp. In prevalent patients, 48% were 65 years or older, 62% were male, the most common PRD was of miscellaneous origin (18%), 56% of patients received haemodialysis, 5% received peritoneal dialysis, and 39% were living with a functioning graft. In 2022, the kidney transplantation rate was 40 pmp, with a majority of kidneys coming from deceased donors (66%). For patients starting KRT between 2013 to 2017, 5-year survival probability was 52%. Compared with the general population, the expected remaining lifetime was 66% and 68% shorter for males and females receiving dialysis, and 46% and 49% shorter for males and females living with a functioning graft.
AB - BackgroundThe European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with end-stage kidney disease (ESKD). This paper summarizes the ERA Registry Annual Report 2022, with a special focus on comparisons by sex. The supplement of this paper contains the complete ERA Registry Annual Report 2022.MethodsData was collected from 53 national and regional KRT registries from 35 countries. Using this data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities and expected remaining lifetimes were calculated.ResultsIn 2022, 530 million people of the European general population were covered by the ERA Registry. The incidence of KRT was 152 per million population (pmp). In incident patients, 54% were 65 years or older, 64% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22%). At KRT initiation, 83% of patients received haemodialysis, 12% received peritoneal dialysis, and 5% underwent preemptive kidney transplantation. On 31 December 2022, the prevalence of KRT was 1 074 pmp. In prevalent patients, 48% were 65 years or older, 62% were male, the most common PRD was of miscellaneous origin (18%), 56% of patients received haemodialysis, 5% received peritoneal dialysis, and 39% were living with a functioning graft. In 2022, the kidney transplantation rate was 40 pmp, with a majority of kidneys coming from deceased donors (66%). For patients starting KRT between 2013 to 2017, 5-year survival probability was 52%. Compared with the general population, the expected remaining lifetime was 66% and 68% shorter for males and females receiving dialysis, and 46% and 49% shorter for males and females living with a functioning graft.
U2 - 10.1093/ckj/sfae405
DO - 10.1093/ckj/sfae405
M3 - Review article
SN - 2048-8505
JO - Clinical Kidney Journal
JF - Clinical Kidney Journal
M1 - sfae405
ER -